HUVEC were lysed in a culture dish by adding 0.5 mL of ice-cold RIPA lysis buffer. The supernatants were collected by centrifugation at 15,000× g for 10 min at 4 °C and then incubated with IgG (Cell Signaling Technology) or FGF1 in the presence or absence of FA at 4 °C overnight, followed by incubation with anti-FGF1 (Abcam) for 4 h. Then, supernatants were incubated with protein G-Sepharose (Santa Cruz) for 4 h. Following the removal of the supernatant by brief centrifugation (6000× g), the protein G-Sepharose was washed 3 times with lysis buffer and then boiled for 5 min in loading buffer. Immunoprecipitates were further analyzed by Western blotting using anti-FGFR1 antibody (1:1000, Abcam), anti-FGF1 antibody (1:1000, Abcam) and anti-FGFR2 (1:1000, Abcam).
Plasmids and Transfection
The short small interfering RNA (siRNA) was constructed by Nanjing GenScript Biotechnology Co., Ltd. (Nanjing, China), with the sequence specifically targeted to the FGFR1 gene (5′-GAAGUGCAUACACCGAGAC-3′) and the FGFR2 gene (5′-GGACGGCACACCCUACGUU-3′). Transient transfection was performed using the Lipofectamine RNAi MAX reagent (Invitrogen) and following the manufacturer's instructions. After transfection, cell proliferation was measured by the MTT assay. Figure S1 . (A) Inhibition of FGFR2 kinase activity by FA was analyzed. Data are expressed as the percentages of the vehicle control. Data are from three independent experiments and are the mean ± SD. n = 3; (B) Inhibition of FGFR1 kinase activity by FA or SSR128129E was analyzed. Data are expressed as the percentages of the vehicle control. Data are from three independent experiments and are the mean ± SD. n = 3. 15 μg/well for 96-well culture plates and 2 μg/well for six-well culture plates). Western blot shows that the FGFR1 was elevated in control cells, siCTL and siFGFR1-transfected cells. GAPDH was used as a loading control; (B) Proliferation assays indicated that FGFR1-siRNA and FGFR2-siRNA exerted inhibition on HUVEC proliferation in vitro. Data are from three independent experiments and are the mean ± SD. n = 3, ** p < 0.01 compared to the control; (C) The proliferation inhibitory effects of FA on HUVEC was abolished by FGFR1 siRNA. Data are from three independent experiments and are the mean ± SD. n = 3, ** p < 0.01 vs. the control. (A) B16F10 cells were transfected with FGFR2 siRNA or FGFR1 siRNA (0.15 μg/well in 96-well culture plates for the MTT assay and 2 μg/well in six-well culture plates for Western blot assay). Western blot shows that the FGFR1 and FGFR2 were elevated in control cells, siCTL and siFGFR-transfected cells. GAPDH was used as the loading control; (B) Proliferation assays indicated that FGFR1-siRNA and FGFR2-siRNA exerted inhibition on B16F10 cell proliferation in vitro. Data are from three independent experiments and are the mean ± SD. n = 3, ** p < 0.01 compared to the control; (C) The proliferation inhibitory effects of FA on B16F10 were abolished by FGFR1 siRNA. Data are from three independent experiments and are the mean ± SD. n = 3, * p < 0.05; ** p < 0.01 vs. the control.
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